Monica Clark, OTR/L | |
502 4th St Ne, Auburn, WA 98002-5020 | |
(253) 931-4927 | |
Not Available |
Full Name | Monica Clark |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 502 4th St Ne, Auburn, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245580448 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 00003694 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Monica Clark, OTR/L 29610 114th Ave Se, Auburn, WA 98092-2564 Ph: () - | Monica Clark, OTR/L 502 4th St Ne, Auburn, WA 98002-5020 Ph: (253) 931-4927 |
News Archive
Inter Press Service examines efforts to curb maternal mortality in Mozambique. The article profiles the work of English medical doctor Peg Cumberland and her team, who have trained "around 400 local people in remote health care" since she came to the country more than 13 years ago.
ICON plc,, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the official opening of a purpose-built clinical pharmacology unit within the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. Initial studies in the unit utilising translational medicine methodologies to expedite drug development projects began in June, and already 110 volunteers have participated in studies there.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has acquired the worldwide development and commercialization rights to the novel topical therapeutic for psoriasis and atopic dermatitis, PAP-1. Circassia acquired the rights to the proprietary molecule from Airmid Inc, for an undisclosed upfront sum plus milestone payments and royalties on future product sales.
In the treatment of large tumors, how effective is adoptive T cell therapy in comparison to drug-based cancer treatment? To answer this question, Dr. Kathleen Anders and Professor Thomas Blankenstein of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and researchers of the Beckman Research Institute of the City of Hope Cancer Center in Duarte, California, USA designed and carried out a study comparing the two methods. Based on a mouse cancer model, the researchers elucidated the mechanisms of the two different treatments.
› Verified 1 days ago
Gabrielle Golinvaux, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 2nd St Sw Ste 110, Auburn, WA 98001 Phone: 253-237-3405 | |
Tess Morgan, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 2nd St Sw Ste 110, Auburn, WA 98001 Phone: 253-237-3405 | |
Miriam Grace Alexander, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 2nd St Sw Ste 110, Auburn, WA 98001 Phone: 253-237-3405 | |
Quincy Marie Mortimer, OTR/L, CLT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 502 29th St Se, Auburn, WA 98002 Phone: 253-939-0090 | |
Rachel Mieko Kasashima, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 110 2nd St Sw Ste 110, Auburn, WA 98001 Phone: 253-237-3405 | |
Adam D Ostrowski, BS/OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 122 3rd St Ne, Auburn, WA 98002 Phone: 253-833-7750 Fax: 253-887-9804 | |
Robin Jo Ritter, COTA/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 502 4th St Ne, Auburn, WA 98002 Phone: 253-931-4927 |